Le singole particelle di farmaco offrono una sensazione di morbidezza e piacevolezza in bocca, senza retrogusto.
Microincapsulazione mediante coacervazione:
- Rivestimento uniforme di una particella solida o di una goccia liquida con un polimero rigido semipermeabile
- Crea una barriera fisica
- Efficace mascheramento del gusto
- Profilo di rilascio personalizzato
- Trasformazione di liquidi non acquosi in polveri
- Combinare API incompatibili
Le forme di dosaggio finali possono essere prodotte in:
- Polveri
- Sciroppi secchi
- Compresse disintegrabili per via orale
- Forma di dosaggio Parvulet®: consistenza morbida simile a quella di un alimento
Parlare con un esperto
Srinivasan Shanmugam, Ph.D.
Direttore senior, Scienze farmaceutiche, supporto alle imprese e nuove tecnologie
Dr. Srinivasan Shanmugam is involved in the development and expansion of Adare’s pharmaceutical technology portfolio and supports product development, co-development, and tech transfer opportunities. Dr. Shanmugam has a Ph.D. M.S., and a B.S. in Pharmacy. Dr. Shanmugam has more than 20 years of experience in designing and development of conventional, NDDS/alternate, advanced/modified drug delivery systems, and pharmaceutical platform technologies for oral and other routes of administration. His expertise includes enabling technologies for challenging drugs and developing platform technologies. Additionally, his expertise includes patient-centric solutions focusing on pediatric and geriatric populations to achieve dose convenience, flexibility, and precision. Dr. Shanmugam has published numerous research articles, holds multiple patents, and is a reviewer/editorial member of various prestigious journals. Shanmugam’s recent work focuses on product development solutions for special patient populations like pediatric and geriatric populations.
